Recommendation: Hold

Current price: Rs 376 (at the time of publishing this tip)

Price target: Under review

Key points:

The US Food and Drug Administration has banned and issued an import alert over 30 generic medicines manufactured at Ranbaxy Laboratories’ Dewas and Paonta Sahib plants in India. In the interim, the FDA will not approve any new product approval applications for products made from these two plants. This could lead to a delay in the approval and launch of generic Valtrex (which features amongst …

Read complete post >>

In the current economic scenario where inflation is threatening to get out of control, investors need to invest in asset classes, which have a positive correlation with inflation. Gold is one such asset which has historically done well during periods of high inflation. This is because during such times investors shift their holdings toward hard assets as the purchasing power of paper money starts dwindling.

An analysis of the price of gold during the high inflationary period of 1970’s in the …

Read complete post >>

Technology companies are facing headwinds from multiple factors. The condition of banking & financial services clients from the USA is only getting worse. The malaise is spreading to the European region, which was initially touted as an important region to offset the likely slowdown in the business from the US geography, with the data from both UK and Germany showing distinct signs of an impending slowdown. This puts a question mark on the possible revival of demand in the latter part …

Read complete post >>

Recommendation: Hold

Current price: Rs 249 (at the time of publishing this tip)

Price target: Rs 266

Key points:

HCL Technologies is likely to make a counter bid for Axon Group Plc. The offer price is anticipated to be at GBP 468 million which is at 15% premium to Infosys Technologies’ offer of GBP 407.1 million. At HCL’s offer price, Axon is valued at 1.7x its CY2009 consensus revenue estimate and 18.3x its CY2009 consensus earnings estimate.
The financing for Axon deal is likely to …

Read complete post >>

Recommendation: Buy

Current price = Rs 454 (at the time of publishing this tip)

Price target: Rs 828

Key points:

Mahindra Lifespace Developers (MLD) reported a healthy consolidated financial performance during FY2008. The company’s top line grew by 6.8% during the year. The operating profit margin expanded by 14.1% to 28.3% mainly because of an improvement in the operating profit on a standalone basis and of improved margins of Mahindra World City Developers Chennai subsidiary.
The development of special economic zones (SEZs) at Chennai and …

Read complete post >>

Making a living out of the Internet can be exciting, but it can also get disappointing & tiring… Many people, including me, struggle to earn a decent revenue from the Internet. Yet many other just dream… Most of the make-money-online experts would freeze upon one single most-important method to start earning sustainable income: Build Your Own Site.

You can build your own site through many ways - Freely hosted sites (Blogger, Wordpress) / Paid hosting sites (Dreamhost, GoDaddy). I am not …

Read complete post >>

Ever noticed how driving at an constant average speed gives you maximum efficiency?

The same is true for your investments. When the markets are volatile, the safest thing is to start a Systematic Investment Plan (SIP). By investing small amounts, month after month, you not only take advantage of fluctuating prices and balance out your risks but also become a disciplined investor.

Five Ways you benefit from SIP:

You get the advantage of Rupee Cost Averaging
Hassle-free and convenient investing method
Get bigger benefits by …

Read complete post >>